Apyx Medical (APYX) Income from Non-Controlling Interests (2013 - 2026)
Apyx Medical (APYX) reported Income from Non-Controlling Interests of -$35000.0 for Q1 2026, down 59.09% on a YoY basis from -$85555.6 in Q1 2025, and down 159.32% quarter-over-quarter from $59000.0 in Q4 2025.
Apyx Medical (APYX) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends
Apyx Medical has reported Income from Non-Controlling Interests for 10 years, with the latest figure at -$35000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests fell 59.09% year-over-year to -$35000.0; the trailing twelve-month figure through Mar 2026 stood at $93000.0 (up 189.42% YoY), and the FY2025 full-year result was $106000.0, up 210.42% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at -$35000.0, down from $59000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $59000.0 in Q4 2025, with the low at -$49000.0 in Q1 2023.
- Historically, Income from Non-Controlling Interests has averaged -$15058.8 across 5 years, with a median of -$23000.0 in 2022.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests plunged 475.0% — and 2025, when it surged 290.32%.
- Apyx Medical's Income from Non-Controlling Interests stood at -$16000.0 in 2022, then dropped by 6.25% to -$17000.0 in 2023, then sank by 82.35% to -$31000.0 in 2024, then surged by 290.32% to $59000.0 in 2025, then tumbled by 159.32% to -$35000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$35000.0 (Q1 2026), $59000.0 (Q4 2025), and $29000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | Apyx Medical | 179.34 Mn | 148.46 Mn | 7.93 Mn | -35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | -31,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | -17,000.00 |
| Sep 30, 2023 | -46,000.00 |
| Jun 30, 2023 | -25,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | -31,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | -5,000.00 |